European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

Novartis data at ASCO and EHA showcase latest oncology research and innovation, including in breast and prostate cancer

by Marie Weil
May 13, 2022
A A
Share on LinkedinShare on Twitter
  • Latest in HR+/HER2- metastatic breast cancer, including data on CDK recycling with Kisqali® plus endocrine therapy, further MONALEESA-2 quality of life and overall survival analyses, and a new biomarker analysis of Piqray® plus fulvestrant
  • Data for Tafinlar®+ Mekinist®in pediatric patients with BRAF V600 low-grade glioma to be featured in ASCO official press briefing
  • First release of 96-week data on Scemblix® in Ph+ CML in chronic phase patients previously treated with ?2 prior tyrosine kinase inhibitors
  • Updated next-generation CAR-T T-Charge™ data, and five-year results from ELIANA trial in pediatric and young adult ALL treated with Kymriah®, the first ever CAR-T cell therapy approved
  • Data from nearly 130 abstracts from Novartis-sponsored and investigator-initiated trials demonstrates Novartis commitment to push the boundaries of science and harness the power of innovation in established and investigational therapies and novel combinations

Basel, May 12, 2022 — Novartis highlights data from across its oncology portfolio at the upcoming 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2022 Hybrid Congress. With nearly 130 abstracts from Novartis-sponsored and investigator-initiated trials accepted, the data showcase research across over 20 compounds in key disease areas, including breast, lung and prostate cancers, leukemia, lymphoma, multiple myeloma and other blood disorders.

“We continue to push the boundaries of science with advanced therapies and novel combinations to help address the individual needs of patients,” said Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, Novartis. “We are particularly excited about the latest data on CDK recycling with Kisqali, and first results for Tafinlar + Mekinist in a rare pediatric brain cancer.”

Tags: < Innovation

Related Industries

Health

AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases

October 16, 2026
Health

Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million

September 30, 2026
Health

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation

September 17, 2026
Health

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

September 15, 2026
Health

Exor and Philips Extend Long-term Relationship Agreement

August 11, 2026
Health

Vanderbilt Health and Siemens Healthineers Launch $87M Value Partnership to Deliver Advanced Technology, Elevate Patient Care

July 28, 2026

Hilton and Scandic Sign New Nordics Strategic Agreement

October 20, 2026

...

ZEISS acquires Ceres Holographics to accelerate holography industrialization

October 9, 2026

...

Volvo Cars and NVIDIA expand partnership to advance safe automated driving

October 16, 2026

...

IHG Hotels & Resorts hits 1,000 open hotels in Europe

October 23, 2026

...

AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases

October 16, 2026

...

“Invest in Germany Summit”: Amazon Announces 16 Billion Euro Investment in Germany in 2027

October 21, 2026

...

AkzoNobel and Axalta to be called Axanzo following merger

October 16, 2026

...

DHL Group plans more than EUR 400 million investment to support growth and supply chain resilience in Central and Eastern Europe

October 9, 2026

...

Siemens partners with NVIDIA to advance AI-driven, autonomous factories

October 20, 2026

...

IBM and Siemens Collaborate on Research to Advance Nanostack Architecture

October 15, 2026

...

European Business European Business European Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist